Pieter Borger, Pierre‐Alain Clavien – 15 September 2016

Graziano Oldani, Stéphanie Lacotte, Lorenzo A. Orci, Vaihere Delaune, Florence Slits, Quentin Gex, Philippe Morel, Laura Rubbia‐Brandt, Christian Toso – 12 September 2016 – Because of the wide availability of genetically modified animals, mouse orthotopic liver transplantation is often preferred over rat liver transplantation. We present a simplified mouse liver transplantation technique and compare transplantation outcomes with versus without hepatic artery anastomosis. Instruments for liver implantation were designed and printed with a 3‐dimensional (3D) printer.

Sasan Roayaie, Morris Sherman, Lewis R. Roberts – 12 September 2016

Harshad Devarbhavi, Sujata Raj – 12 September 2016

Franco Trevisani, Laura Bucci, Francesca Garuti, for the Italian Liver Cancer (ITA.LI.CA) group – 12 September 2016

Amir Kashani, H. G. Lipshutz, Andrew S. Klein, Irene Kim, Marc L. Friedman, Juvelyn Palomique, Vinay Sundaram – 12 September 2016

Inmaculada Medina‐Cáliz, Mercedes Robles‐Díaz, M. Isabel Lucena, Raul J. Andrade – 12 September 2016

Jason A. Wertheim – 9 September 2016

In‐Gu Jun, Byungdoo Lee, Seon‐Ok Kim, Won‐Jung Shin, Ji‐Youn Bang, Jun‐Gol Song, Gi‐Won Song, Sung‐Gyu Lee, Gyu‐Sam Hwang – 6 September 2016 – The anti‐CD20 monoclonal antibody rituximab has significantly decreased the prevalence of antibody‐mediated rejection of ABO‐incompatible (ABOi) living donor liver transplantation (LDLT). However, little is known about acute kidney injury (AKI) following ABOi LDLT. The aim of this study was to identify the incidence of AKI in ABOi LDLT and compare it with that of ABO‐compatible (ABOc) LDLT.

Helge Eilers – 6 September 2016